The First Affiliated Hospital of Soochow University
363
121
135
53
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.7%
6 terminated/withdrawn out of 363 trials
89.8%
+3.3% vs industry average
14%
50 trials in Phase 3/4
8%
4 of 53 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (363)
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)
Role: collaborator
The Application of Multimodal Artificial Intelligence Systems in Prostate Cancer Diagnosis and Prognosis Analysis
Role: collaborator
Application of a Novel Model Based on Plasma cfDNA Assay and MRl Imaging in the Detection of Prostate Cancer
Role: collaborator
A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure
Role: collaborator
A Single-center, Prospective, Single-arm Clinical Study Exploring the Treatment of Newly Diagnosed Multiple Myeloma Patients With t(11;14) Suitable for Transplantation Using the SonKRd Regimen
Role: lead
A Clinical Study Comparing the Effectiveness and Safety of Two Surgical Pathways for Laparoscopic Total Hysterectomy
Role: lead
A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Role: lead
A Cohort Study Comparing PCSK9 Inhibitor Plus Statin With Statin Monotherapy for Carotid Artery Stenosis
Role: collaborator
CMV-CMI in csCMVi After HSCT
Role: lead
PDCA-Based Precision Nursing for Stroke Patients With Tracheostomy
Role: lead
Study of IBR733 Cell Injection in Acute Myeloid Leukemia
Role: collaborator
Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis
Role: lead
eCASH and Early Goal-Directed Mobilization to Prevent ICU-Acquired Weakness
Role: lead
VA Consolidation in Intermediate-Risk AML
Role: lead
Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis
Role: collaborator
Younger vs. Older Donors in Allo-HSCT: TTE
Role: lead
Cousin vs. Sibling Donors in Haplo-HSCT
Role: lead
Venetoclax Combined With Azacitidine for Consolidation Therapy in AML
Role: lead
Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML
Role: lead
Endofaster Robot for Gastroesophageal Submucosal Tumors: A Randomized Controlled Study
Role: lead